Viewing Study NCT03718533

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-25 @ 3:01 AM
Ignite Modification Date: 2026-03-03 @ 7:39 PM
Study NCT ID: NCT03718533
Status: TERMINATED
Last Update Posted: 2024-02-29
First Post: 2018-10-23
Is NOT Gene Therapy: True
Has Adverse Events: True
Brief Title: Study of Efficacy and Safety of Eltrombopag in Patients With Poor Graft Function
Sponsor: Novartis Pharmaceuticals
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Poor Graft Function View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Eltrombopag View
None Hematological response View
None Poor graft function View
None Stem cell transplantation View
None Adult View
None ELTION View
None Phase II View